Cargando…
Clinical outcomes of breakthrough COVID-19 after booster vaccination in patients with systemic rheumatic diseases
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918070/ https://www.ncbi.nlm.nih.gov/pubmed/35246472 http://dx.doi.org/10.1136/rmdopen-2022-002279 |
| _version_ | 1784668654297677824 |
|---|---|
| author | Fragoulis, George E Karamanakos, Anastasios Arida, Aikaterini Bournia, Vasiliki-Kalliopi Evangelatos, Gerasimos Fanouriakis, Antonis Fragiadaki, Kalliopi Kravvariti, Evrydiki Laskari, Katerina Panopoulos, Stylianos Papazoglou, Nikolaos Pappa, Maria Tektonidou, Maria G Sfikakis, Petros P |
| author_facet | Fragoulis, George E Karamanakos, Anastasios Arida, Aikaterini Bournia, Vasiliki-Kalliopi Evangelatos, Gerasimos Fanouriakis, Antonis Fragiadaki, Kalliopi Kravvariti, Evrydiki Laskari, Katerina Panopoulos, Stylianos Papazoglou, Nikolaos Pappa, Maria Tektonidou, Maria G Sfikakis, Petros P |
| author_sort | Fragoulis, George E |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8918070 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | BMJ Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89180702022-03-14 Clinical outcomes of breakthrough COVID-19 after booster vaccination in patients with systemic rheumatic diseases Fragoulis, George E Karamanakos, Anastasios Arida, Aikaterini Bournia, Vasiliki-Kalliopi Evangelatos, Gerasimos Fanouriakis, Antonis Fragiadaki, Kalliopi Kravvariti, Evrydiki Laskari, Katerina Panopoulos, Stylianos Papazoglou, Nikolaos Pappa, Maria Tektonidou, Maria G Sfikakis, Petros P RMD Open Infections BMJ Publishing Group 2022-03-04 /pmc/articles/PMC8918070/ /pubmed/35246472 http://dx.doi.org/10.1136/rmdopen-2022-002279 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Infections Fragoulis, George E Karamanakos, Anastasios Arida, Aikaterini Bournia, Vasiliki-Kalliopi Evangelatos, Gerasimos Fanouriakis, Antonis Fragiadaki, Kalliopi Kravvariti, Evrydiki Laskari, Katerina Panopoulos, Stylianos Papazoglou, Nikolaos Pappa, Maria Tektonidou, Maria G Sfikakis, Petros P Clinical outcomes of breakthrough COVID-19 after booster vaccination in patients with systemic rheumatic diseases |
| title | Clinical outcomes of breakthrough COVID-19 after booster vaccination in patients with systemic rheumatic diseases |
| title_full | Clinical outcomes of breakthrough COVID-19 after booster vaccination in patients with systemic rheumatic diseases |
| title_fullStr | Clinical outcomes of breakthrough COVID-19 after booster vaccination in patients with systemic rheumatic diseases |
| title_full_unstemmed | Clinical outcomes of breakthrough COVID-19 after booster vaccination in patients with systemic rheumatic diseases |
| title_short | Clinical outcomes of breakthrough COVID-19 after booster vaccination in patients with systemic rheumatic diseases |
| title_sort | clinical outcomes of breakthrough covid-19 after booster vaccination in patients with systemic rheumatic diseases |
| topic | Infections |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918070/ https://www.ncbi.nlm.nih.gov/pubmed/35246472 http://dx.doi.org/10.1136/rmdopen-2022-002279 |
| work_keys_str_mv | AT fragoulisgeorgee clinicaloutcomesofbreakthroughcovid19afterboostervaccinationinpatientswithsystemicrheumaticdiseases AT karamanakosanastasios clinicaloutcomesofbreakthroughcovid19afterboostervaccinationinpatientswithsystemicrheumaticdiseases AT aridaaikaterini clinicaloutcomesofbreakthroughcovid19afterboostervaccinationinpatientswithsystemicrheumaticdiseases AT bourniavasilikikalliopi clinicaloutcomesofbreakthroughcovid19afterboostervaccinationinpatientswithsystemicrheumaticdiseases AT evangelatosgerasimos clinicaloutcomesofbreakthroughcovid19afterboostervaccinationinpatientswithsystemicrheumaticdiseases AT fanouriakisantonis clinicaloutcomesofbreakthroughcovid19afterboostervaccinationinpatientswithsystemicrheumaticdiseases AT fragiadakikalliopi clinicaloutcomesofbreakthroughcovid19afterboostervaccinationinpatientswithsystemicrheumaticdiseases AT kravvaritievrydiki clinicaloutcomesofbreakthroughcovid19afterboostervaccinationinpatientswithsystemicrheumaticdiseases AT laskarikaterina clinicaloutcomesofbreakthroughcovid19afterboostervaccinationinpatientswithsystemicrheumaticdiseases AT panopoulosstylianos clinicaloutcomesofbreakthroughcovid19afterboostervaccinationinpatientswithsystemicrheumaticdiseases AT papazoglounikolaos clinicaloutcomesofbreakthroughcovid19afterboostervaccinationinpatientswithsystemicrheumaticdiseases AT pappamaria clinicaloutcomesofbreakthroughcovid19afterboostervaccinationinpatientswithsystemicrheumaticdiseases AT tektonidoumariag clinicaloutcomesofbreakthroughcovid19afterboostervaccinationinpatientswithsystemicrheumaticdiseases AT sfikakispetrosp clinicaloutcomesofbreakthroughcovid19afterboostervaccinationinpatientswithsystemicrheumaticdiseases |